Pangaea Data

Pangaea Data is London and South San Francisco based provider of a software product platform to help healthcare and pharmaceutical providers to find untreated patients and bring them into screening. Such untreated patients include undiagnosed, misdiagnosed, miscoded , uncontrolled and at risk patients who comprise up-to 90% of the patient population across hard to diagnose conditions. Pangaea achieves so by mimicking a clinicians manual process to achieve the same based on clinical guidelines so the results are explainable for clinicians and there is zero disruption for clinical and IT teams. The founders at Pangaea have secured more than $300 million...

Machine learning,automation,scientific and clinical data processing,making data meaningful,accessible and usable for analysis and interpretation,identification of patients,optimizing drug discovery and development,early diagnosis,metadata tagging of ehr data,optimizing clinical trials,enabling precision medicine,large language models,generative ai,characterizing patients,untreated patients,undiagnosed,misdiagnosed,miscoded,population health,point of care,ai,and artificial intelligence

Pangaea data operates in the Biotechnology research industry.

Pangaea data's revenue is 11m - 100m

Pangaea data has 11 - 50 employees.